These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 12559804)

  • 61. Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection.
    Shlapobersky M; Marshak JO; Dong L; Huang ML; Wei Q; Chu A; Rolland A; Sullivan S; Koelle DM
    J Gen Virol; 2012 Jun; 93(Pt 6):1305-1315. PubMed ID: 22398318
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms.
    Aberle JH; Aberle SW; Allison SL; Stiasny K; Ecker M; Mandl CW; Berger R; Heinz FX
    J Immunol; 1999 Dec; 163(12):6756-61. PubMed ID: 10586074
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Optimized DNA Vaccine Enhanced by Adjuvant IL28B Induces Protective Immune Responses Against Herpes Simplex Virus Type 2 in Mice.
    Zhou Y; Wang Z; Xu Y; Zhang Z; Hua R; Liu W; Jiang C; Chen Y; Yang W; Kong W
    Viral Immunol; 2017 Oct; 30(8):601-614. PubMed ID: 28650722
    [TBL] [Abstract][Full Text] [Related]  

  • 64. LFA-3 plasmid DNA enhances Ag-specific humoral- and cellular-mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells in protection.
    Sin JI; Kim J; Dang K; Lee D; Pachuk C; Satishchandran C; Weiner DB
    Cell Immunol; 2000 Jul; 203(1):19-28. PubMed ID: 10915558
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prophylactic herpes simplex virus type 2 vaccine adjuvanted with a universal CD4 T cell helper peptide induces long-term protective immunity against lethal challenge in mice.
    Li X; Zhang S; Lei J; Zhu Y; Zhou X; Xiao J; Xiang T
    Int Immunopharmacol; 2018 Aug; 61():100-108. PubMed ID: 29857239
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cholera toxin conjugates for intragastric vaccination against herpes simplex virus type 2.
    Drew MD; Estrada AE; Underdown BJ; McDermott MR
    Reg Immunol; 1992; 4(2):79-85. PubMed ID: 1503890
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of herpes simplex virus-1 gD or gD-IL-2 DNA vaccine on herpetic keratitis.
    Inoue T; Inoue Y; Hayashi K; Shimomura Y; Fujisawa Y; Aono A; Tano Y
    Cornea; 2002 Oct; 21(7 Suppl):S79-85. PubMed ID: 12484704
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Macrophage inflammatory protein-1alpha expression plasmid enhances DNA vaccine-induced immune responses against HSV-2.
    Shao W; Li X; Li M; Shi L; Qin Y; Li K
    Immunol Cell Biol; 2005 Dec; 83(6):626-31. PubMed ID: 16266314
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Enhanced immune responses to E2 protein and DNA formulated with ISA 61 VG administered as a DNA prime-protein boost regimen against bovine viral diarrhea virus.
    Cai D; Song Q; Duan C; Wang S; Wang J; Zhu Y
    Vaccine; 2018 Sep; 36(37):5591-5599. PubMed ID: 30077483
    [TBL] [Abstract][Full Text] [Related]  

  • 70. DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model.
    Sin JI; Bagarazzi M; Pachuk C; Weiner DB
    DNA Cell Biol; 1999 Oct; 18(10):771-9. PubMed ID: 10541436
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine.
    An LL; Rodriguez F; Harkins S; Zhang J; Whitton JL
    Vaccine; 2000 Apr; 18(20):2132-41. PubMed ID: 10715528
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
    Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Construction and Immunogenicity Analysis of Herpes Simplex Virus Type 2 Glycoprotein D Recombinant Adenovirus Vaccine].
    Liu W; Zhao D; Wang Z; Li Y; Wang H; Wang H
    Bing Du Xue Bao; 2016 May; 32(3):267-72. PubMed ID: 29962197
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice.
    Tengvall S; Josefsson A; Holmgren J; Harandi AM
    J Reprod Immunol; 2005 Dec; 68(1-2):53-69. PubMed ID: 16229896
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Protective immunity against herpes simplex virus generated by DNA vaccination compared to natural infection.
    Nass PH; Elkins KL; Weir JP
    Vaccine; 2001 Jan; 19(11-12):1538-46. PubMed ID: 11163680
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A novel DNA vaccine technology conveying protection against a lethal herpes simplex viral challenge in mice.
    Dutton JL; Li B; Woo WP; Marshak JO; Xu Y; Huang ML; Dong L; Frazer IH; Koelle DM
    PLoS One; 2013; 8(10):e76407. PubMed ID: 24098493
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A vaccinia virus--herpes simplex virus (HSV) glycoprotein B1 recombinant or an HSV vaccine overcome the HSV type 2 induced humoral immunosuppression and protect against vaginal challenge in BALB/c mice.
    Fleck M; Podlech J; Weise K; Falke D
    Med Microbiol Immunol; 1994 May; 183(2):87-94. PubMed ID: 7935163
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Humoral and cellular immune responses to herpes simplex virus-2 glycoprotein D generated by facilitated DNA immunization of mice.
    Pachuk CJ; Arnold R; Herold K; Ciccarelli RB; Higgins TJ
    Curr Top Microbiol Immunol; 1998; 226():79-89. PubMed ID: 9479837
    [No Abstract]   [Full Text] [Related]  

  • 79. Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection.
    Caselli E; Grandi P; Argnani R; Balboni PG; Selvatici R; Manservigi R
    Intervirology; 2001; 44(1):1-7. PubMed ID: 11223713
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.
    Hu K; Dou J; Yu F; He X; Yuan X; Wang Y; Liu C; Gu N
    Vaccine; 2011 Feb; 29(7):1455-62. PubMed ID: 21185849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.